Evaluation of biosite triage Clostridium difficile panel for rapid detection of Clostridium difficile in stool samples

被引:25
作者
Landry, ML
Topal, J
Ferguson, D
Giudetti, D
Tang, Y
机构
[1] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA
[3] Yale New Haven Hosp, Clin Virol Lab, New Haven, CT 06504 USA
[4] Yale New Haven Hosp, Dept Qual Improvement & Support Serv, New Haven, CT 06504 USA
[5] Univ Calif Davis, Dept Internal Med, Sacramento, CA 95817 USA
关键词
D O I
10.1128/JCM.39.5.1855-1858.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
One hundred two steal samples were tested by both the rapid Triage Clostridium difficile Panel (Triage Panel) and the cytotoxin cell culture assay. Five samples positive by both the C. difficile toxin A (Tox A) and common antigen components of the Triage Panel had cytotoxin titers of greater than or equal to 10,000. Twenty-three samples were Triage Panel Tox A negative but common antigen positive. Ten of these had cytotoxin titers of 10 to 1,000, but 13 were cytotoxin negative. Bacterial isolates obtained from 8 of these 13 specimens were analyzed for Tox A and B genes by PCR, and only two contained toxigenic bacteria. Thus, the majority of samples positive only for C. difficile common antigen contained nontoxigenic bacteria. A Triage Panel Tox A-positive result indicated a sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of 33.3, 100, 100, and 88.2%, respectively. A Triage Panel common antigen-positive result indicated a sensitivity, specificity, PPV, and NPV of 100, 82.7, 53.6, and 100%, respectively. The high NPV of the Triage Panel common antigen, together with rapid reporting of results, should prove useful in avoiding unnecessary use of contact precautions and antibiotic treatment for C. difficile-negative patients. However, with Triage Panel common antigen-positive patients, a sensitive cytotoxin assay should be used to distinguish true cytotoxin-positive patients from C. difficile carriers.
引用
收藏
页码:1855 / 1858
页数:4
相关论文
共 14 条
[1]   CYTO-TOXICITY ASSAY IN ANTIBIOTIC-ASSOCIATED COLITIS [J].
CHANG, TW ;
LAUERMANN, M ;
BARTLETT, JG .
JOURNAL OF INFECTIOUS DISEASES, 1979, 140 (05) :765-770
[2]   ACQUISITION OF CLOSTRIDIUM-DIFFICILE BY HOSPITALIZED-PATIENTS - EVIDENCE FOR COLONIZED NEW ADMISSIONS AS A SOURCE OF INFECTION [J].
CLABOTS, CR ;
JOHNSON, S ;
OLSON, MM ;
PETERSON, LR ;
GERDING, DN .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (03) :561-567
[3]   Isolation of various genotypes of Clostridium difficile from patients and the environment in an oncology ward [J].
Cohen, SH ;
Tang, YJ ;
Muenzer, J ;
Gumerlock, PH ;
Silva, J .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (05) :889-893
[4]   NONTOXIGENIC STRAINS OF CLOSTRIDIUM-DIFFICILE LACK THE GENES FOR BOTH TOXIN-A AND TOXIN-B [J].
FLUIT, AC ;
WOLFHAGEN, MJHM ;
VERDONK, GPHT ;
JANSZE, M ;
TORENSMA, R ;
VERHOEF, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (11) :2666-2667
[5]  
Garner Julia S., 1996, Infection Control and Hospital Epidemiology, V17, P53
[6]  
GERDING DN, 1997, CLIN INFECT DIS S2, V25, P206
[7]  
GUMERLOCK PH, 1991, REV INFECT DIS, V13, P1053
[8]   Clostridium difficile -: Associated diarrhea [J].
Johnson, S ;
Gerding, DN .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (05) :1027-1034
[9]   CLOSTRIDIUM-DIFFICILE COLITIS [J].
KELLY, CP ;
POTHOULAKIS, C ;
LAMONT, JT .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (04) :257-262
[10]   DIAGNOSIS AND MONITORING OF CLOSTRIDIUM-DIFFICILE INFECTIONS WITH THE POLYMERASE CHAIN-REACTION [J].
KUHL, SJ ;
TANG, YJ ;
NAVARRO, L ;
GUMERLOCK, PH ;
SILVA, J .
CLINICAL INFECTIOUS DISEASES, 1993, 16 :S234-S238